On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. Experts emphasized ...

YolTech Therapeutics CEO and founder Dr Yuxuan Wu said: "The initiation of the clinical trial for YOLT-204 represents a ...

YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204 , an investigational ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT.

The companies will focus on next-generation gene therapies for sickle cell disease and transfusion-dependent beta thalassemia. Credit: da-kuk via Getty Images ... editing them in a laboratory using ...

Generation Beta is starting and entering into a world with AI, including the potential for ... [+] artificial general intelligence (AGI) and the vaunted artificial superintelligence (ASI).

In a historic moment for India, the country welcomed its first ‘Generation Beta’ baby as a boy was born at Synod Hospital in Aizawl, the capital of Manipur’s northeastern state, shortly ...

Children born on and after January 1, 2025, will now be termed as Generation Beta or Gen Beta. The last time the world went through a generational shift was in 2010 when Gen Alpha babies were born, ...